Universitätsklinikum Frankfurt am Main (KGU)

Karyotype complexity and prognosis in acute myeloid leukemia (2016) Stoelzel F, Mohr B, Kramer M, Oelschlaegel U, Bochtler T, Berdel WE, Kaufmann M, et al. Journal article Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial (2016) Middeke JM, Herbst R, Parmentier S, Bug G, Haenel M, Stuhlers G, Schaefer-Eckart K, et al. Journal article Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases (2016) Klement RJ, Allgaeuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, et al. Journal article Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients (2016) Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, et al. Journal article Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy (2016) Guckenberger M, Klement RJ, Allgaeuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, et al. Journal article Effects of In utero environment and maternal behavior on neuroendocrine and behavioral alterations in a mouse model of prenatal trauma (2016) Golub Y, Canneva F, Funke R, Frey S, Distler J, von Hörsten S, Freitag CM, et al. Journal article Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD (2016) Ho AD, Schetelig J, Bochtler T, Schaich M, Schaefer-Eckart K, Haenel M, Rösler W, et al. Journal article German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging (2016) Barthel H, Meyer PT, Drzezga A, Bartenstein P, Boecker H, Brust P, Buchert R, et al. Journal article Eradication of measles: remaining challenges (2016) Holzmann H, Hengel H, Tenbusch M, Doerr HW Journal article, Review article MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive Glioblastoma: The DIRECTOR Trial (2015) Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, et al. Journal article